Cowen Inc’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Cowen Inc’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,000	Closed	-$1.16M	–	360
2017 Q3	$1.16M	Buy	+20,000	New	+$2.15M	0.04%	121

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Cowen Inc's ICPT Position: Q4 2017 in Review

Cowen Inc sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2017, closing a stake of 20,000 shares — an estimated $1.16M sold.

Cowen Inc first reported a position in ICPT in Q3 2017 and held it in 1 quarter. The position peaked at $1.16M in Q3 2017. 168 funds tracked by Wall St. Rank hold ICPT as of Q4 2017.

Cowen Inc reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Cowen Inc sold 20,000 Intercept Pharmaceuticals, Inc. shares in Q4 2017, an estimated $1.16M.
Cowen Inc first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 1 quarter.
Cowen Inc's Intercept Pharmaceuticals, Inc. position peaked at $1.16M in Q3 2017.
168 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2017.

Based on Cowen Inc's 13F filing for Q4 2017, filed 15 Feb 2018.